Bruker and Agilent Enter Into Definive Asset Purchase Agreement
Bruker to Acquire Certain Varian Product Lines
Bruker and Agilent Technologies announced that they have entered into a definitive asset purchase agreement. Pursuant to this agreement, Bruker will acquire certain product lines of Varian Inc., which Agilent has committed to divest in connection with obtaining regulatory approval for Agilent's previously announced acquisition of Varian.
The product lines to be acquired by Bruker include:
- Varian's global inductively coupled plasma mass spectrometry (ICP-MS) instruments business located in Melbourne, Australia;
- Varian's global laboratory gas chromatography (Lab GC) instruments business located in Middelburg, the Netherlands; and
- Varian's global gas chromatography triple-quadrupole mass spectrometry (GC-QQQ) instruments business located in Walnut Creek, California.
The transaction is subject to customary closing conditions and regulatory approvals, and is expected to close shortly after Agilent completes its acquisition of Varian (which Agilent anticipates to occur by April 30, 2010, following the completion of regulatory reviews and clearances). There is no financing condition to closing the transaction. Transaction pricing was not disclosed; the transaction is not material to Agilent.